No abstract available
Publication types
-
Clinical Trial, Phase II
-
Letter
-
Multicenter Study
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
ADP-ribosyl Cyclase 1 / blood*
-
Antibodies, Monoclonal / administration & dosage
-
Antibodies, Monoclonal / adverse effects*
-
Erythrocytes* / metabolism
-
Erythrocytes* / pathology
-
Female
-
Humans
-
Male
-
Membrane Glycoproteins / blood*
-
Multiple Myeloma* / blood
-
Multiple Myeloma* / diet therapy
-
Multiple Myeloma* / pathology
Substances
-
Antibodies, Monoclonal
-
Membrane Glycoproteins
-
daratumumab
-
CD38 protein, human
-
ADP-ribosyl Cyclase 1